A28 Therapeutics
A28 Therapeutics is a Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.
This record contains identity and selected historical facts. Business areas, products and practical answers have not been added.
Data formats & record details
Download this profile and inspect its supporting evidence.
Data access & reuse
- Wikidata data accessWikidata · 2026-07-29
- Wikidata reuse permissionWikidata · 2026-07-29
- CC0 1.0 UniversalWikidata · 2026-07-29
- Entity ID
- urn:readyscan:entity:a28-therapeutics-q139829650
- Material fingerprint
- fnv1a64:ca4e30c6fe186816
- Entity revision
- fnv1a64:ae0ac04a616e6ba7
- Published
- 2026-07-29
- Modified
- 2026-07-29
- Source summary
- A28 Therapeutics: Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer. Website: https://www.a28therapeutics.com